Attorneys in the European Practice have counselled issuers or investment banking firms in a wide range of equity and debt
security offerings relating to either public or private issuers.
Representative Transactions
- Amsterdam Molecular Therapeutics. Advising Amsterdam Molecular Therapeutics, a Dutch biopharmaceutical company, on its €50 million Initial Public Offering
on Euronext, Amsterdam.
- Ardana Plc. Advising Ardana on its successful initial public offering on the UK Official List and related £21 million fundraising.
- CeNeS Pharmaceuticals plc. Advising long-term client CeNeS on several placings.
- Eureka Mining PLC. Advising Williams de Bröe as underwriter to a secondary offering by Eureka on the Alternative Investment Market.
- Future Internet Technologies plc. Advising Future Internet Technologies on a placing of 145 million new Ordinary Shares to raise £50.75 million; on a £7.9
million secondary placing underwritten by Fiske plc; and on a further share placing to raise approximately £3 million in connection
with the acquisition of share capital of Artilium NV that FIT did not already own.
- Intercytex Group plc. Advising Intercytex, a Cambridge-based emerging healthcare company, on its Initial Public Offer on the Alternative Investment
Market. Subsequently advising on a £12 million placing of new ordinary shares to institutional investors in the UK and continental
Europe.
- Northwest Biotherapeutics, Inc. Advising Collins Stewart as underwriter on the placing and admission to AIM of common shares in Northwest Biotherapeutics,
Inc.
- Oxford Biomedica. Advising Oxford Biomedica, a gene therapy company listed on the UK official list, on a placing and open offer and related
investment by Sigma-Aldrich to raise £30.1 million. Subsequently representing the company in a follow on fundraising in connection
with its £16 million acquisition of Oxxon Therapeutics.
- Plethora Solutions Plc. Advising Plethora on its successful initial public offering on the Alternative Investment Market and related fundraising.
Also advising the company on its fundraising in connection with the related acquisition of Timm Medical.
- ReNeuron Group plc. Advising ReNeuron, the UK-based adult stem cell research and development company, on its successful initial public offering
on the Alternative Investment Market. Subsequently advising the company on a further placing. Also advising ReNeuron on a
placing in connection with the acquisition of the business assets of AmCyte Inc., a development stage cell therapy company
based in Santa Monica, California.
- Renovo Group plc. Representing Renovo on its initial public offer on the Official List raising £57.5 million and simultaneously advising on
the issuance of up to £15 million of Convertible Loan Notes to existing investors.
- Shore Capital. Representing Shore Capital on the U.S. aspects of the offering and Alternative Investment Market listing of UTEK Corporation.
- Silverjet plc. Representing this airline, which offers only business-class service, on its initial public offer on the Alternative Investment
Market and related £25 million fundraising. Subsequently advising the company on a placing to raise approximately £26 million.
- Weatherly International. Advising Weatherly on a placing, reverse takeover of Ongopolo Mining and Processing Company and admission to AIM. Subsequently
advising the company on several further placings.
